K181372

Substantially Equivalent

Argos

Applicant: Retia Medical, LLC
Product code: DXG
Advisory panel: Cardiovascular
Date received: 2018-05-23
Decision date: 2018-12-13
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Valhalla, NY, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.